查看分析师 EPS 与营收区间、覆盖人数，以及过去 7、30、90 天的预期变化。缺失修正不会显示成零；分析师人数较少的公司默认不进入排名。
| 公司 | 财年 EPS | 预期区间 | 分析师 | 7 日 | 30 日 | 90 日 | 30 日上调 / 下调 | 营收预期 |
|---|---|---|---|---|---|---|---|---|
| REGN Regeneron Pharmaceuticals Inc. Common Stock | 50.38 2026-12-31 | 45.77 – 58.33 | 20 | +9.87% | +9.01% | +8.63% | 0 / 1 | $16.66B |
| WST West Pharmaceutical Services Inc. Common Stock | 8.94 2026-12-31 | 8.58 – 9.05 | 16 | +2.73% | +3.78% | +3.66% | 1 / 1 | $3.37B |
| M Macy's Inc Common Stock | 2.21 2027-01-31 | 2.05 – 2.31 | 13 | +0.37% | +2.43% | +4.94% | 10 / 1 | $21.78B |
| BMA Banco Macro S.A. ADR (representing Ten Class B Common Shares) | 9,792.55 2026-12-31 | 8,442.8 – 11,278.92 | 3 | +1.73% | +1.73% | +17.51% | 3 / 0 | $5.69T |
| LGND Ligand Pharmaceuticals Incorporated Common Stock | 9.18 2026-12-31 | 8.79 – 9.68 | 8 | +0.30% | +0.91% | +6.33% | 2 / 2 | $289.77M |
| INDV Indivior Pharmaceuticals Inc. Common Stock | 3.85 2026-12-31 | 3.63 – 4.05 | 5 | +0.78% | +0.78% | +23.49% | 4 / 0 | $1.26B |
| AMRX Amneal Pharmaceuticals Inc. Class A Common Stock | 0.99 2026-12-31 | 0.94 – 1.03 | 5 | +1.43% | +0.64% | -0.35% | 2 / 1 | $3.14B |
| COLL Collegium Pharmaceutical Inc. Common Stock | 7.76 2026-12-31 | 7.29 – 8.18 | 4 | +0.58% | +0.58% | +5.19% | 4 / 1 | $869.86M |
| ANIP ANI Pharmaceuticals Inc. | 9.42 2026-12-31 | 9.19 – 9.68 | 8 | +0.11% | +0.58% | +3.83% | 7 / 0 | $1.12B |
| MTSI MACOM Technology Solutions Holdings Inc. Common Stock | 5.03 2026-09-30 | 4.89 – 5.31 | 14 | +0.01% | +0.06% | +12.27% | 15 / 0 | $1.26B |
| GRDN Guardian Pharmacy Services Inc. Class A Common Stock | 1.26 2026-12-31 | 1.2 – 1.34 | 6 | 0.00% | 0.00% | +2.94% | 3 / 0 | $1.41B |
| SUPN Supernus Pharmaceuticals Inc. Common Stock | 2.49 2026-12-31 | 2.11 – 2.95 | 3 | 0.00% | 0.00% | +6.27% | 0 / 0 | $867.18M |
| BMRN BioMarin Pharmaceutical Inc. Common Stock | 4.93 2026-12-31 | 4.86 – 5.03 | 17 | -0.10% | -0.05% | -7.84% | 1 / 0 | $3.87B |
| JAZZ Jazz Pharmaceuticals plc Common Stock (Ireland) | 25.31 2026-12-31 | 24.38 – 26.99 | 17 | -0.30% | -0.32% | +4.79% | 0 / 1 | $4.51B |
| RIGL Rigel Pharmaceuticals Inc. Common Stock | 2.89 2026-12-31 | 0.64 – 4.01 | 4 | -0.77% | -0.77% | -39.72% | 0 / 1 | $278.89M |
| VRTX Vertex Pharmaceuticals Incorporated Common Stock | 18.98 2026-12-31 | 17.61 – 19.85 | 20 | +0.07% | -0.88% | -0.61% | 14 / 10 | $13.05B |
| IBM International Business Machines Corporation Common Stock | 12.33 2026-12-31 | 12.08 – 12.63 | 24 | +2.20% | -1.04% | -0.79% | 2 / 1 | $70.38B |
| AUPH Aurinia Pharmaceuticals Inc Ordinary Shares | 0.95 2026-12-31 | 0.85 – 1.04 | 5 | -1.04% | -1.04% | +21.28% | 1 / 0 | $325.82M |
| PMT PennyMac Mortgage Investment Trust Common Shares of Beneficial Interest | 1.17 2026-12-31 | 1.04 – 1.55 | 6 | -1.41% | -1.41% | -28.23% | 0 / 5 | $345M |
| AMPH Amphastar Pharmaceuticals Inc. Common Stock | 2.6 2026-12-31 | 2.26 – 2.94 | 7 | -0.87% | -2.88% | -20.36% | 0 / 1 | $746.37M |
| ALNY Alnylam Pharmaceuticals Inc. Common Stock | 9.09 2026-12-31 | 8.22 – 9.92 | 12 | -3.58% | -3.55% | -1.98% | 0 / 1 | $5.58B |
| TEVA Teva Pharmaceutical Industries Limited American Depositary Shares | 2.14 2026-12-31 | 1.91 – 2.94 | 12 | -0.78% | -3.63% | -10.64% | 0 / 4 | $16.58B |
| ACAD ACADIA Pharmaceuticals Inc. Common Stock | 0.37 2026-12-31 | 0.27 – 0.51 | 13 | 0.00% | -4.07% | -24.73% | 0 / 1 | $1.24B |
| KNSA Kiniksa Pharmaceuticals International plc Class A Ordinary Shares | 1.13 2026-12-31 | 1.07 – 1.18 | 3 | -2.30% | -5.56% | -3.96% | 0 / 0 | $993.71M |
| PFSI PennyMac Financial Services Inc. Common Stock | 7.32 2026-12-31 | 7.15 – 7.5 | 4 | -24.51% | -29.89% | -36.13% | 0 / 1 | $2.23B |
| ABOS Acumen Pharmaceuticals Inc. Common Stock | -1.58 2026-12-31 | -1.76 – -1.32 | 3 | — | — | — | 2 / 0 | $0 |
| AGIO Agios Pharmaceuticals Inc. Common Stock | -6.14 2026-12-31 | -7.21 – -5.5 | 7 | — | — | — | 0 / 1 | $130.56M |
| AMLX Amylyx Pharmaceuticals Inc. Common Stock | -1.43 2026-12-31 | -1.59 – -1.27 | 7 | — | — | — | 3 / 4 | $0 |
| ARWR Arrowhead Pharmaceuticals Inc. Common Stock | -3.08 2026-09-30 | -3.82 – -1.85 | 11 | — | — | — | 2 / 0 | $442.33M |
| CRBP Corbus Pharmaceuticals Holdings Inc. Common Stock | -4.57 2026-12-31 | -5.7 – -3.31 | 10 | — | — | — | 4 / 4 | $1.11M |
| CRNX Crinetics Pharmaceuticals Inc. Common Stock | -4.62 2026-12-31 | -5.28 – -3.48 | 13 | — | — | — | 0 / 1 | $68.49M |
| CRVS Corvus Pharmaceuticals Inc. Common Stock | -0.71 2026-12-31 | -0.8 – -0.65 | 4 | — | — | — | 0 / 3 | $0 |
| DMAC DiaMedica Therapeutics Inc. Common Stock | -0.83 2026-12-31 | -0.9 – -0.76 | 4 | — | — | — | 2 / 2 | $0 |
| ELDN Eledon Pharmaceuticals Inc. Common Stock | -0.87 2026-12-31 | -0.92 – -0.77 | 4 | — | — | — | 2 / 0 | $0 |
| ENTA Enanta Pharmaceuticals Inc. Common Stock | -1.88 2026-09-30 | -2.27 – -1.39 | 4 | — | — | — | 2 / 1 | $66.34M |
| EPRX Eupraxia Pharmaceuticals Inc. Common Stock | -0.98 2026-12-31 | -1.17 – -0.78 | 8 | — | — | — | 0 / 5 | $0 |
| FENC Fennec Pharmaceuticals Inc. Common Stock | 0.3 2026-12-31 | 0.18 – 0.47 | 5 | -2.95% | — | -52.87% | 4 / 2 | $69.83M |
| HUMA Humacyte Inc. Common Stock | -0.35 2026-12-31 | -0.37 – -0.32 | 3 | — | — | — | 3 / 0 | $6.34M |
| IONS Ionis Pharmaceuticals Inc. Common Stock | -2.65 2026-12-31 | -2.69 – -2.62 | 4 | — | — | — | 1 / 0 | $926.6M |
| LBRX LB Pharmaceuticals Inc Common Stock | -3.35 2026-12-31 | -3.72 – -2.75 | 7 | — | — | — | 4 / 0 | $0 |
| LXRX Lexicon Pharmaceuticals Inc. Common Stock | -0.16 2026-12-31 | -0.18 – -0.14 | 5 | — | — | — | 2 / 0 | $38.17M |
| METC Ramaco Resources Inc. Class A Common Stock | -0.75 2026-12-31 | -1.14 – -0.46 | 8 | — | — | — | 0 / 5 | $596.75M |
| MIST Milestone Pharmaceuticals Inc. Common Shares | -0.83 2026-12-31 | -0.99 – -0.74 | 4 | — | — | — | 0 / 2 | $5.39M |
| OLMA Olema Pharmaceuticals Inc. Common Stock | -2.27 2026-12-31 | -2.62 – -1.95 | 9 | — | — | — | 4 / 5 | $0 |
| ORIC Oric Pharmaceuticals Inc. Common Stock | -1.47 2026-12-31 | -1.66 – -1.3 | 13 | — | — | — | 2 / 8 | $0 |
| PHAT Phathom Pharmaceuticals Inc. Common Stock | -0.08 2026-12-31 | -0.13 – -0.01 | 3 | — | — | — | 1 / 1 | $326.35M |
| RARE Ultragenyx Pharmaceutical Inc. Common Stock | -4.19 2026-12-31 | -4.27 – -4.12 | 3 | — | — | — | 0 / 2 | $748.3M |
| RCKT Rocket Pharmaceuticals Inc. Common Stock | -0.75 2026-12-31 | -1.98 – -0.12 | 6 | — | — | — | 2 / 1 | $17.17M |
| RXRX Recursion Pharmaceuticals Inc. Class A Common Stock | -0.92 2026-12-31 | -1 – -0.84 | 6 | — | — | — | 6 / 0 | $64.74M |
| RYTM Rhythm Pharmaceuticals Inc. Common Stock | -3.26 2026-12-31 | -3.87 – -2.82 | 11 | — | — | — | 1 / 0 | $299.04M |
| SNDX Syndax Pharmaceuticals Inc. Common Stock | -1.6 2026-12-31 | -2.2 – -1.16 | 11 | — | — | — | 1 / 1 | $344.78M |
| SPRY ARS Pharmaceuticals Inc. Common Stock | -1.72 2026-12-31 | -2.05 – -1.27 | 3 | — | — | — | 2 / 0 | $139.84M |
| TITN Titan Machinery Inc. Common Stock | -1.45 2027-01-31 | -1.61 – -1.3 | 4 | — | — | — | 2 / 1 | $2.11B |
| TLX Telix Pharmaceuticals Limited American Depositary Shares | 0.07 2026-12-31 | -0.04 – 0.24 | 5 | — | — | — | 1 / 0 | $1.4B |
| VNDA Vanda Pharmaceuticals Inc. Common Stock | -2.27 2026-12-31 | -2.68 – -1.98 | 4 | — | — | — | 3 / 2 | $262.1M |
| VRCA Verrica Pharmaceuticals Inc. Common Stock | -1.73 2026-12-31 | -1.83 – -1.57 | 3 | — | — | — | 2 / 0 | $25.53M |
| XENE Xenon Pharmaceuticals Inc. Common Shares | -4.81 2026-12-31 | -5.94 – -3.88 | 16 | — | — | — | 6 / 7 | $2.07M |
| XFOR X4 Pharmaceuticals Inc. Common Stock | -0.73 2026-12-31 | -0.96 – -0.63 | 5 | — | — | — | 2 / 0 | $9.6M |
| ZNTL Zentalis Pharmaceuticals Inc. Common Stock | -1.67 2026-12-31 | -2.19 – -1.33 | 6 | — | — | — | 0 / 1 | $0 |
默认至少 3 位分析师。没有历史值、EPS 非正值或历史 EPS 过于接近零时显示“—”，不会用失真的百分比参与排名。
榜单优先使用当前财年 EPS；营收修正由每日快照逐步积累，首日不会生成伪历史。